Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

Detalles Bibliográficos
Autores principales: Yamada, Hideto, Deguchi, Masashi, Saito, Shigeru, Takeshita, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440280/
https://www.ncbi.nlm.nih.gov/pubmed/36065419
http://dx.doi.org/10.1016/j.eclinm.2022.101617
_version_ 1784782307010281472
author Yamada, Hideto
Deguchi, Masashi
Saito, Shigeru
Takeshita, Toshiyuki
author_facet Yamada, Hideto
Deguchi, Masashi
Saito, Shigeru
Takeshita, Toshiyuki
author_sort Yamada, Hideto
collection PubMed
description
format Online
Article
Text
id pubmed-9440280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94402802022-09-04 Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial Yamada, Hideto Deguchi, Masashi Saito, Shigeru Takeshita, Toshiyuki eClinicalMedicine Correspondence Elsevier 2022-08-27 /pmc/articles/PMC9440280/ /pubmed/36065419 http://dx.doi.org/10.1016/j.eclinm.2022.101617 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Yamada, Hideto
Deguchi, Masashi
Saito, Shigeru
Takeshita, Toshiyuki
Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
title Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
title_full Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
title_fullStr Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
title_full_unstemmed Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
title_short Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
title_sort author's reply – intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: a double-blind, randomised, placebo-controlled trial
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440280/
https://www.ncbi.nlm.nih.gov/pubmed/36065419
http://dx.doi.org/10.1016/j.eclinm.2022.101617
work_keys_str_mv AT yamadahideto authorsreplyintravenousimmunoglobulintreatmentinwomenwithfourormorerecurrentpregnancylossesadoubleblindrandomisedplacebocontrolledtrial
AT deguchimasashi authorsreplyintravenousimmunoglobulintreatmentinwomenwithfourormorerecurrentpregnancylossesadoubleblindrandomisedplacebocontrolledtrial
AT saitoshigeru authorsreplyintravenousimmunoglobulintreatmentinwomenwithfourormorerecurrentpregnancylossesadoubleblindrandomisedplacebocontrolledtrial
AT takeshitatoshiyuki authorsreplyintravenousimmunoglobulintreatmentinwomenwithfourormorerecurrentpregnancylossesadoubleblindrandomisedplacebocontrolledtrial

Ejemplares similares